PALB2/FANCN: Recombining Cancer and Fanconi Anemia

被引:146
作者
Tischkowitz, Marc [1 ,2 ,3 ]
Xia, Bing [4 ,5 ]
机构
[1] McGill Univ, Program Canc Genet, Dept Oncol, Montreal, PQ, Canada
[2] Jewish Gen Hosp, Segal Canc Ctr, Lady Davis Inst, Montreal, PQ H3T1E2, Canada
[3] McGill Univ, Program Canc Genet, Dept Human Genet & Med, Montreal, PQ, Canada
[4] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA
[5] Univ Med & Dent New Jersey, Canc Inst New Jersey, Dept Radiat Oncol, New Brunswick, NJ USA
关键词
BRCA2-INTERACTING PROTEIN PALB2; ONSET BREAST-CANCER; SUSCEPTIBILITY GENE; OVARIAN-CANCER; POLY(ADP-RIBOSE) POLYMERASE; HOMOLOGOUS RECOMBINATION; BIALLELIC MUTATIONS; GERMLINE MUTATIONS; PANCREATIC-CANCER; BRCA2;
D O I
10.1158/0008-5472.CAN-10-1012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Partner and localizer of BRCA2 (PALB2) was originally identified as a BRCA2-interacting protein that is crucial for key BRCA2 genome caretaker functions. It subsequently became clear that PALB2 was another Fanconi anemia (FA) gene (FANCN), and that monoallelic PALB2 mutations are associated with increased risk of breast and pancreatic cancer. Mutations in PALB2 have been identified in breast cancer families worldwide, and recent studies have shown that PALB2 also interacts with BRCA1. Here, we summarize the molecular functions and clinical phenotypes of this key DNA repair pathway component and discuss how its discovery has advanced our knowledge of both FA and adult cancer predisposition. Cancer Res; 70(19); 7353-9. (C) 2010 AACR.
引用
收藏
页码:7353 / 7359
页数:7
相关论文
共 49 条
[1]   Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2 [J].
Alter, Blanche P. ;
Rosenberg, Philip S. ;
Brody, Lawrence C. .
JOURNAL OF MEDICAL GENETICS, 2007, 44 (01) :1-9
[2]   Fanconi anemia and its diagnosis [J].
Auerbach, Arleen D. .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2009, 668 (1-2) :4-10
[3]   BRCA1 induces antioxidant gene expression and resistance to oxidative stress [J].
Bae, I ;
Fan, S ;
Meng, QH ;
Rih, JK ;
Kim, HJ ;
Kang, HJ ;
Xu, JW ;
Goldberg, ID ;
Jaiswal, AK ;
Rosen, EM .
CANCER RESEARCH, 2004, 64 (21) :7893-7909
[4]   Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase [J].
Bryant, HE ;
Schultz, N ;
Thomas, HD ;
Parker, KM ;
Flower, D ;
Lopez, E ;
Kyle, S ;
Meuth, M ;
Curtin, NJ ;
Helleday, T .
NATURE, 2005, 434 (7035) :913-917
[5]   Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories? [J].
Byrnes, Graham B. ;
Southey, Melissa C. ;
Hopper, John L. .
BREAST CANCER RESEARCH, 2008, 10 (03)
[6]   The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives [J].
Cao, A-Yong ;
Huang, Juan ;
Hu, Zhen ;
Li, Wen-Feng ;
Ma, Zhong-Liang ;
Tang, Li-Li ;
Zhang, Bin ;
Su, Feng-Xi ;
Zhou, Jie ;
Di, Gen-Hong ;
Shen, Kun-Wei ;
Wu, Jiong ;
Lu, Jin-Song ;
Luo, Jian-Min ;
Yuan, Wen-Tao ;
Shen, Zhen-Zhou ;
Huang, Wei ;
Shao, Zhi-Ming .
BREAST CANCER RESEARCH AND TREATMENT, 2009, 114 (03) :457-462
[7]   Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells [J].
Chen, JJ ;
Silver, DP ;
Walpita, D ;
Cantor, SB ;
Gazdar, AF ;
Tomlinson, G ;
Couch, FJ ;
Weber, BL ;
Ashley, T ;
Livingston, DM ;
Scully, R .
MOLECULAR CELL, 1998, 2 (03) :317-328
[8]   MECHANISMS OF DISEASE Susceptibility Pathways in Fanconi's Anemia and Breast Cancer [J].
D'Andrea, Alan D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (20) :1909-1919
[9]   A novel germline PALB2 deletion in Polish breast and ovarian cancer patients [J].
Dansonka-Mieszkowska, Agnieszka ;
Kluska, Anna ;
Moes, Joanna ;
Dabrowska, Michalina ;
Nowakowska, Dorota ;
Niwinska, Anna ;
Derlatka, Pawel ;
Cendrowski, Krzysztof ;
Kupryjanczyk, Jolanta .
BMC MEDICAL GENETICS, 2010, 11
[10]   The genetic and molecular basis of Fanconi anemia [J].
de Winter, Johan P. ;
Joenje, Hans .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2009, 668 (1-2) :11-19